Showing results (261-270 of 430) with videos related to

Sort By:
Pageof 43
Molecular Cancer Therapeutics|September 26, 2014
Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agentsNicholas C L Wong, Phyllis F Y Cheung, Chi Wai Yip, et al.
Molecular Cancer Therapeutics|September 21, 2006
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisZhen Fan Yang, Ronnie T P Poon, Yuqing Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluationJohn M Luk, Xiaoling Wang, Ping Liu, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 11, 2004
Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral centerKelvin Kwok-Chai Ng, Ronnie Tung-Ping Poon, Chung-Mau Lo, et al.
Cancer Research|January 25, 2005
Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinomaZhen Fan Yang, David W Ho, Chi Tat Lam, et al.
Plos One|May 3, 2011
Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transitionChris K Sun, Kevin T Ng, Zophia X Lim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 11, 2013
Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging systemAlbert C Y Chan, Sheung Tat Fan, Ronnie T P Poon, et al.
Annals of Surgery|February 22, 2013
Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinomaAlbert C Y Chan, Tan To Cheung, Sheung Tat Fan, et al.
Cancer Biology & Therapy|December 7, 2007
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinomaChi Keung Lau, Zhen Fan Yang, Shuk Pik Lam, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Long-term expression of angiostatin suppresses metastatic liver cancer in miceRuian Xu, Xueying Sun, Lai-Yin Tse, et al.
Pageof 43